| Literature DB >> 33897714 |
Samer R Khan1,2, Anna C van der Burgh1,3, Robin P Peeters1,4, P Martin van Hagen2,5, Virgil A S H Dalm2,5, Layal Chaker1,4.
Abstract
Background: An up-to-date overview of determinants of serum immunoglobulins in adults is pivotal for clinical practice and research, but currently lacking. We therefore performed a systematic review and meta-analysis to identify determinants of serum immunoglobulin levels.Entities:
Keywords: adult human beings; determinants; meta-analysis; serum immunoglobulins; systematic review
Year: 2021 PMID: 33897714 PMCID: PMC8058410 DOI: 10.3389/fimmu.2021.664526
Source DB: PubMed Journal: Front Immunol ISSN: 1664-3224 Impact factor: 7.561
Summarized descriptive statistics of included studies.
| Determinant | N studies | Design | Continents | Ethnicities | Range N participants | Range age participants | Included immunoglobulins |
|---|---|---|---|---|---|---|---|
| Age | 41 | Cross-sectional (39), before-after study (1), non-randomized controlled clinical trial (1) | North America (12), Europe (22), Asia (7), | Caucasian (18), African (5), Asian (4), Other (3), NR (17) | 20-3213 | 18-106 | IgA (34), IgG (37), IgM (36) |
| Sex | 36 | Cross-sectional (35), before-after study (1) | North America (7), Europe (19), Asia (6), | Caucasian (16), African (7), Asian (5), Other (5), NR (10) | 12-3213 | 18-98 | IgA (30), IgG (30), IgM (32) |
| Diet | 23 | Cross-sectional (3), before-after study (10), non-randomized controlled clinical trial (2), RCT (8) | North America (4), Europe (8), Asia (9), Africa (2) | Caucasian (2), Asian (8), Other (1), NR (12) | 5-1291 | 18-90 | IgA (20), IgG (21), IgM (19) |
| Ethnicity | 18 | Cross-sectional (18) | North America (4), | Caucasian (14), African (9), Asian (6), Other (6) | 30-1799 | 18-95 | IgA (17), IgG (17), IgM (16) |
| Smoking | 12 | Cross-sectional (12) | North America (2), Europe (5), Asia (4), Australia (1) | Caucasian (3), African (1), Asian (2), Other (1), NR (6) | 23-3508 | 18-92 | IgA (8), IgG (11), IgM (9) |
| Hormones (endogenous and exogenous) | 8 | Cross-sectional (2), before-after study (3), non-randomized controlled clinical trial (1), RCT (2) | North America (3), Europe (3), South America (1), Africa (1) | Caucasian (1), African (1), Other (1), NR (5) | 9-200 | 18-69 | IgA (7), IgG (7), IgM (6) |
| Alcohol consumption | 6 | Cross-sectional (3), before-after study (2), RCT (1) | Europe (3), Asia (2), Australia (1) | Caucasian (2), Asian (2), NR (2) | 5-3508 | 18-92 | IgA (3), IgG (4), IgM (3) |
| Cardiometabolic risk factors | 4 | Cross-sectional (4) | Europe (2), Asia (2) | Caucasian (2), Asian (2) | 174-12 373 | 18-92 | IgA (3), IgG (4), IgM (4) |
| Other life style factors | 12 | Cross-sectional (1), before-after study (7), RCT (4) | North America (2), Europe (2), Asia (6), South America (1), Australia (1) | Asian (3), Other (1), NR (8) | 2-76 | 19-63 | IgA (9), IgG (12), IgM (10) |
| Miscellaneous | 8 | Cross-sectional (5), before-after study (2), longitudinal (1) | North America (1), Europe (6), Asia (1) | Caucasian (3), NR (4), Asian (1) | 15-927 | 18-94 | IgA (8), IgG (8), IgM (8) |
Some studies included multiple countries/ethnicities.
Comprises relaxation techniques (n=1), aromatherapy (n=1), massage (n=1), Tai Chi (n=1), exercise (n=1), psychological stress (n=4), and sleep deprivation (n=3).
Comprises intelligence (n=1), amoxicillin/clavulanic acid (n=1), air pollution (n=1), external temperature (n=2), and blood group (n=3).
NR, not reported; IgA, immunoglobulin A; IgG, immunoglobulin G; IgM, immunoglobulin M; RCT, randomized controlled trial.
Figure 1Forest plots for the association between age and serum immunoglobulin levels. (A) Association of age with serum immunoglobulin A (IgA) (g/l). (B) Association of age with serum immunoglobulin G (IgG) (g/l). (C) Association of age with serum immunoglobulin M (IgM) (g/l). The closed squares with horizontal lines depict the mean differences in serum immunoglobulin levels between older (≥45 years) and young (<45 years) subjects with 95% confidence intervals. The diamonds depict the pooled mean differences between the older and young age groups. The random effect model was taken as primary model.
Figure 2Forest plots for the association between sex and serum immunoglobulin levels. (A) Association of sex with serum immunoglobulin A (IgA) (g/l). (B) Association of sex with serum immunoglobulin G (IgG) (g/l). (C) Association of sex with serum immunoglobulin M (IgM) (g/l). The closed squares with horizontal lines depict the mean differences in serum immunoglobulin levels between men and women with 95% confidence intervals. The diamonds depict the pooled mean differences between men and women. The random effect model was taken as primary model.
Sensitivity and stratified meta-analyses for effect of age: older vs younger age groups.
| Immunoglobulin | N studies | Total N older (≥45y) | Total N young (<45y) | Fixed Effect Mean Difference (95% CI) | Random Effect Mean Difference (95% CI) | I2 statistic | τ2 statistic | ||
|---|---|---|---|---|---|---|---|---|---|
|
| |||||||||
| IgA | 6 | 286 | 205 | 0.21 (0.11 - 0.31) | 0.39 (0.11 - 0.67) | 72% | 0.0663 | ||
| IgG | 8 | 359 | 285 | -3.03 (-3.35 - -2.70) | -0.36 (-3.10 - 2.39) | 97% | 14.7443 | ||
| IgM | 9 | 451 | 507 | -0.53 (-0.59 - -0.47) | -0.56 (-0.86 - -0.25) | 95% | 0.1743 | ||
|
| |||||||||
| IgA | 5 | 159 | 93 | 0.33 (0.18 - 0.47) | 0.33 (0.18 - 0.47) | 0% | 0 | ||
| IgG | 6 | 280 | 265 | -0.19 (-0.62 - 0.24) | -0.19 (-0.62 - 0.24) | 0% | 0 | ||
| IgM | 5 | 129 | 128 | -0.45 (-0.57 - -0.34) | -0.45 (-0.57 - -0.34) | 0% | 0 | ||
|
| |||||||||
| IgA | 4 | 188 | 122 | 0.42 (0.28 - 0.56) | 0.42 (0.28 - 0.56) | 0% | 0 | ||
| IgG | 6 | 308 | 235 | -0.27 (-0.70 - 0.16) | -0.73 (-2.39 - 0.92) | 91% | 3.7091 | ||
| IgM | 6 | 407 | 304 | -0.24 (-0.30 - -0.18) | -0.36 (-0.58 - -0.14) | 89% | 0.0609 | ||
|
| |||||||||
| IgA | 4 | 212 | 197 | 0.17 (0.06 - 0.28) | 0.44 (0.06 - 0.81) | 79% | 0.0921 | ||
| IgG | 6 | 285 | 277 | -3.18 (-3.51 - -2.85) | 0.29 (-2.63 - 3.21) | 97% | 12.4430 | ||
| IgM | 6 | 285 | 277 | -0.63 (-0.71 - -0.55) | -0.39 (-0.93 - 0.15) | 96% | 0.4045 | ||
|
| |||||||||
| IgA | 5 | 154 | 80 | 0.42 (0.25 - 0.60) | 0.51 (0.18 - 0.84) | 52% | 0.0633 | ||
| IgG | 6 | 230 | 150 | -0.10 (-0.70 - 0.50) | -0.63 (-2.85 - 1.59) | 91% | 6.7568 | ||
| IgM | 5 | 154 | 80 | -0.52 (-0.63 - -0.40) | -0.55 (-0.81 - -0.29) | 61% | 0.0454 | ||
|
| |||||||||
| IgA | 1 | 80 | 80 | 0.53 (0.30 - 0.76) | 0.53 (0.30 - 0.76) | NA | NA | ||
| IgG | 3 | 154 | 153 | -0.08 (-0.63 - 0.48) | 0.76 (-0.91 - 2.44) | 77% | 1.5743 | ||
| IgM | 4 | 329 | 292 | -0.13 (-0.20 - -0.06) | -0.15 (-0.30 - 0.01) | 64% | 0.0137 | ||
|
| |||||||||
| IgA | 2 | 166 | 159 | 0.13 (0.02 - 0.24) | 0.15 (-0.01 - 0.30) | 35% | 0.0050 | ||
| IgG | 3 | 209 | 209 | -3.53 (-3.88 - -3.19) | -0.97 (-4.91 - 2.98) | 98% | 11.9020 | ||
| IgM | 3 | 209 | 209 | -0.65 (-0.73 - -0.56) | -0.43 (-1.21 - 0.36) | 98% | 0.4761 | ||
|
| |||||||||
| IgA | NA | NA | NA | NA | NA | NA | NA | ||
| IgG | 2 | 84 | 79 | -0.20 (-1.09 - 0.68) | -0.16 (-1.32 - 1.00) | 40% | 0.2853 | ||
| IgM | 1 | 44 | 43 | 0.03 (-0.14 - 0.20) | 0.03 (-0.14 - 0.20) | NA | NA | ||
|
| |||||||||
| IgA | 1 | 34 | 34 | 0.26 (0.02 - 0.50) | 0.26 (0.02 - 0.50) | NA | NA | ||
| IgG | 3 | 113 | 118 | 0.32 (-0.42 - 1.05) | 0.33 (-0.98 - 1.65) | 67% | 0.8960 | ||
| IgM | 2 | 77 | 84 | -0.01 (-0.15 - 0.14) | -0.13 (-0.70 - 0.44) | 92% | 0.1549 | ||
|
| |||||||||
| IgA | 7 | 366 | 285 | 0.27 (0.17 - 0.36) | 0.42 (0.17 - 0.66) | 75% | 0.0637 | ||
| IgG | 8 | 396 | 315 | -2.65 (-2.94 - -2.36) | -0.63 (-2.92 - 1.66) | 97% | 10.0099 | ||
| IgM | 9 | 571 | 454 | -0.48 (-0.54 - -0.43) | -0.53 (-0.83 - -0.23) | 95% | 0.1700 | ||
Unless stated other cut-off for age groups.
NA, not applicable; NR, not reported.
Sensitivity and stratified meta-analyses for effect of sex: males vs females.
| Immunoglobulin | N studies | Total N Males | Total N Females | Fixed Effect Mean Difference (95% CI) | Random Effect Mean Difference (95% CI) | I2 statistic | τ2 statistic |
|---|---|---|---|---|---|---|---|
|
| |||||||
| IgA | 7 | 425 | 233 | 0.27 (0.16 - 0.37) | 0.27 (0.14 - 0.41) | 21% | 0.0067 |
| IgG | 9 | 1168 | 456 | -0.32 (-0.60 - -0.03) | -0.32 (-0.60 - -0.03) | 0% | 0 |
| IgM | 10 | 1283 | 602 | -0.19 (-0.24 - -0.14) | -0.19 (-0.24 - -0.14) | 0% | 0 |
|
| |||||||
| IgA | 6 | 449 | 291 | 0.06 (-0.01 - 0.13) | 0.30 (0.00 - 0.60) | 92% | 0.1133 |
| IgG | 8 | 566 | 406 | -0.59 (-0.79 - -0.39) | -0.18 (-0.97 - 0.61) | 89% | 0.9542 |
| IgM | 9 | 705 | 537 | -0.27 (-0.31 - -0.22) | -0.25 (-0.34 - -0.16) | 71% | 0.0123 |
|
| |||||||
| IgA | 6 | 994 | 249 | 0.06 (-0.06 - 0.17) | 0.13 (-0.13 - 0.39) | 68% | 0.0575 |
| IgG | 5 | 989 | 239 | -0.53 (-0.88 - -0.19) | -0.67 (-1.24 - -0.11) | 48% | 0.1911 |
| IgM | 6 | 1019 | 289 | -0.01 (-0.05 - 0.04) | -0.15 (-0.31 - 0.01) | 75% | 0.0219 |
|
| |||||||
| IgA | 1 | 40 | 24 | -0.17 (-0.26 - -0.08) | -0.17 (-0.26 - -0.08) | NA | NA |
| IgG | 2 | 116 | 94 | -1.22 (-1.48 - -0.96) | -1.22 (-1.48 - -0.96) | 0% | 0 |
| IgM | 1 | 40 | 24 | -0.33 (-0.40 - -0.26) | -0.33 (-0.40 - -0.26) | NA | NA |
|
| |||||||
| IgA | 6 | 494 | 337 | 0.32 (0.22 - 0.41) | 0.32 (0.16 - 0.48) | 53% | 0.0182 |
| IgG | 7 | 535 | 382 | 0.17 (-0.12 - 0.47) | -0.03 (-0.56 - 0.51) | 62% | 0.2876 |
| IgM | 9 | 750 | 583 | -0.24 (-0.30 - -0.19) | -0.26 (-0.35 - -0.17) | 58% | 0.0103 |
|
| |||||||
| IgA | 2 | 859 | 123 | -0.01 (-0.15 - 0.12) | -0.01 (-0.15 - 0.12) | 0% | 0 |
| IgG | 2 | 859 | 123 | -0.25 (-0.67 - 0.17) | -0.25 (-0.67 - 0.17) | 0% | 0 |
| IgM | 3 | 889 | 173 | -0.14 (-0.25 - -0.03) | -0.14 (-0.25 - -0.03) | 0% | 0 |
|
| |||||||
| IgA | 3 | 50 | 56 | 0.83 (0.27 - 1.38) | 1.03 (-0.22 - 2.27) | 74% | 0.8711 |
| IgG | 2 | 45 | 46 | -1.56 (-2.55 - -0.57) | -1.06 (-3.41 - 1.28) | 39% | 1.5794 |
| IgM | 2 | 45 | 46 | 0.04 (-0.01 - 0.10) | 0.43 (-0.52 - 1.38) | 78% | 0.3834 |
|
| |||||||
| IgA | 3 | 371 | 169 | 0.23 (0.09 - 0.37) | 0.23 (0.09 - 0.37) | 0% | 0 |
| IgG | 5 | 449 | 254 | -0.09 (-0.52 - 0.34) | -0.12 (-0.59 - 0.34) | 6% | 0.0194 |
| IgM | 5 | 475 | 253 | -0.28 (-0.37 - -0.20) | -0.28 (-0.45 - -0.12) | 71% | 0.0238 |
|
| |||||||
| IgA | 5 | 124 | 114 | -0.13 (-0.22 - -0.05) | 0.19 (-0.20 - 0.59) | 80% | 0.1130 |
| IgG | 5 | 158 | 135 | -1.21 (-1.46 - -0.96) | -1.09 (-1.67 - -0.50) | 40% | 0.1692 |
| IgM | 5 | 149 | 154 | -0.09 (-0.13 - -0.05) | -0.08 (-0.35 - 0.20) | 95% | 0.0615 |
|
| |||||||
| IgA | 4 | 948 | 257 | 0.24 (0.14 - 0.34) | 0.25 (-0.03 - 0.53) | 84% | 0.0658 |
| IgG | 4 | 948 | 256 | 0.05 (-0.25 - 0.34) | -0.00 (-0.71 - 0.70) | 81% | 0.3992 |
| IgM | 5 | 1100 | 419 | -0.19 (-0.25 - -0.13) | -0.20 (-0.28 - -0.13) | 30% | 0.0024 |
NA, not applicable; NR, not reported.